Clinical Practice Session
Evidence-Based Management of Septic AKI, Including the Burton D. Rose, MD, Endowed Lectureship
November 04, 2022 | 02:00 PM - 04:00 PM
Location: W307, Orange County Convention Center, West Building
Session Description
Septic AKI is common in critical illness and requires effective multidisciplinary team management to mitigate adverse outcomes. Management of sepsis and septic AKI is guided by evidence-based guidelines that are continuously evolving, informed by large clinical trials. This session reviews the current evidence underpinning the management of sepsis and septic AKI, including insights from the management of COVID-19.
ASN gratefully acknowledges Wolters Kluwer (publisher of UpToDate), the Beth Israel Deaconess Medical Center Department of Medicine Foundation, the Rose Family, and several of Dr. Rose's colleagues for supporting this lectureship.
Learning Objective(s)
- Discuss the timing, choice, and fluid balance management strategy for septic AKI prevention and management
- Describe the approach to choosing and titrating vasoactive drugs in septic shock, to prevent or treat septic AKI and improve clinical outcomes
- Explain the rationale and evidence for the use of corticosteroids in sepsis
- Outline the timing of initiation, dosing, and discontinuation of RRT in septic AKI
Learning Pathway(s)
- AKI and Critical Care
- Dialysis
Moderators
- Jay L. Koyner, MD
- Blaithin A. McMahon, MBChB, PhD
Presentations
- Fluid Management in Septic AKI: When, What Type, and How Much? The Burton D. Rose, MD, Endowed Lectureship
02:00 PM - 02:30 PM
Kathleen D. Liu, MD, PhD, FASN
- Vasoactive Drugs in Septic Shock and AKI: Which Drugs to Use, and Which Parameters to Target?
02:30 PM - 03:00 PM
Lui G. Forni, MBBS, PhD
- Corticosteroid Therapy in Sepsis: Current Recommendations
03:00 PM - 03:30 PM
Marlies Ostermann, MD, PhD
- RRT in Septic AKI: When to Start, How to Dose, and When to Stop?
03:30 PM - 04:00 PM
Ron Wald, MD, MPH
